Plotsker Ethan L, Graziano Francis D, Kim Minji, Boe Lillian A, Tadros Audree B, Matros Evan, Azoury Said C, Nelson Jonas A
Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
J Reconstr Microsurg. 2025 Jan;41(1):9-18. doi: 10.1055/a-2277-0236. Epub 2024 Feb 27.
Insurance type can serve as a surrogate marker for social determinants of health and can influence many aspects of the breast reconstruction experience. We aimed to examine the impact of insurance coverage on patients reported outcomes with the BREAST-Q (patient reported outcome measure for breast reconstruction patients, in patients receiving) in patients receiving deep inferior epigastric artery perforator (DIEP) flap breast reconstruction.
We retrospectively examined patients who received DIEP flaps at our institution from 2010 to 2019. Patients were divided into categories by insurance: commercial, Medicaid, or Medicare. Demographic factors, surgical factors, and complication data were recorded. Descriptive statistics, Fisher's exact, Kruskal-Wallis rank sum tests, and generalized estimating equations were performed to identify associations between insurance status and five domains of the BREAST-Q Reconstructive module.
A total of 1,285 patients were included, of which 1,011 (78.7%) had commercial, 89 (6.9%) had Medicaid, and 185 (14.4%) had Medicare insurances. Total flap loss rates were significantly higher in the Medicare and Medicaid patients as compared to commercial patients; however, commercial patients had a higher rate of wound dehiscence as compared to Medicare patients. With all other factors controlled for, patients with Medicare had lower Physical Well-being of the Chest (PWBC) than patients with commercial insurance (β = - 3.1, 95% confidence interval (CI): -5.0, -1.2, = 0.002). There were no significant associations between insurance classification and other domains of the BREAST-Q.
Patients with government-issued insurance had lower success rates of autologous breast reconstruction. Further, patients with Medicare had lower PWBC than patients with commercial insurance regardless of other factors, while other BREAST-Q metrics did not differ. Further investigation as to the causes of such variation is warranted in larger, more diverse cohorts.
保险类型可作为健康社会决定因素的替代指标,并可能影响乳房重建体验的许多方面。我们旨在研究保险覆盖范围对接受腹壁下深动脉穿支(DIEP)皮瓣乳房重建患者使用BREAST-Q(乳房重建患者报告结局量表)报告的结局的影响。
我们回顾性研究了2010年至2019年在本机构接受DIEP皮瓣手术的患者。患者按保险类型分为:商业保险、医疗补助或医疗保险。记录人口统计学因素、手术因素和并发症数据。进行描述性统计、Fisher精确检验、Kruskal-Wallis秩和检验和广义估计方程,以确定保险状况与BREAST-Q重建模块的五个领域之间的关联。
共纳入1285例患者,其中1011例(78.7%)有商业保险,89例(6.9%)有医疗补助,185例(14.4%)有医疗保险。医疗保险和医疗补助患者的皮瓣完全丢失率显著高于商业保险患者;然而,商业保险患者的伤口裂开率高于医疗保险患者。在控制所有其他因素后,医疗保险患者的胸部身体健康(PWBC)低于商业保险患者(β=-3.1,95%置信区间(CI):-5.0,-1.2,P=0.002)。保险分类与BREAST-Q的其他领域之间无显著关联。
政府发放保险的患者自体乳房重建成功率较低。此外,无论其他因素如何,医疗保险患者的PWBC低于商业保险患者,而其他BREAST-Q指标无差异。有必要在更大、更多样化的队列中进一步调查这种差异的原因。